Literature DB >> 24481242

IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy.

Ebrahim Haroon1, Bobbi J Woolwine1, Xiangchuan Chen2, Thaddeus W Pace3, Samir Parekh4, James R Spivey4, Xiaoping P Hu2, Andrew H Miller1.   

Abstract

Cytokine effects on behavior may be related to alterations in glutamate metabolism. We therefore measured glutamate concentrations in brain regions shown to be affected by inflammatory stimuli including the cytokine interferon (IFN)-alpha. IFN-alpha is known to alter neural activity in the dorsal anterior cingulate cortex (dACC) and basal ganglia in association with symptoms of depression and increases in peripheral cytokines including the tumor necrosis factor (TNF) and its soluble receptor. Single-voxel magnetic resonance spectroscopy (MRS) was employed to measure glutamate concentrations normalized to creatine (Glu/Cr) in dACC and basal ganglia of 31 patients with hepatitis C before and after ∼ 1 month of either no treatment (n = 14) or treatment with IFN-alpha (n = 17). Depressive symptoms were measured at each visit using the Inventory of Depressive Symptoms-Clinician Rating (IDS-C) and the Multidimensional Fatigue Inventory. IFN-alpha was associated with a significant increase in Glu/Cr in dACC and left basal ganglia. Increases in dACC Glu/Cr were positively correlated with scores on the IDS-C in the group as a whole, but not in either group alone. Glu/Cr increases in left basal ganglia were correlated with decreased motivation in the group as a whole and in IFN-alpha-treated subjects alone. No Glu/Cr changes were found in the right basal ganglia, and no significant correlations were found between Glu/Cr and the inflammatory markers. IFN-alpha-induced increases in glutamate in dACC and basal ganglia are consistent with MRS findings in bipolar depression and suggest that inflammatory cytokines may contribute to glutamate alterations in patients with mood disorders and increased inflammation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24481242      PMCID: PMC4023151          DOI: 10.1038/npp.2014.25

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  45 in total

Review 1.  Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders.

Authors:  Cagri Yüksel; Dost Öngür
Journal:  Biol Psychiatry       Date:  2010-08-21       Impact factor: 13.382

2.  Neural sensitivity to social rejection is associated with inflammatory responses to social stress.

Authors:  George M Slavich; Baldwin M Way; Naomi I Eisenberger; Shelley E Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

3.  Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward.

Authors:  Naomi I Eisenberger; Elliot T Berkman; Tristen K Inagaki; Lian T Rameson; Nehjla M Mashal; Michael R Irwin
Journal:  Biol Psychiatry       Date:  2010-08-16       Impact factor: 13.382

4.  Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole.

Authors:  M Banasr; G M I Chowdhury; R Terwilliger; S S Newton; R S Duman; K L Behar; G Sanacora
Journal:  Mol Psychiatry       Date:  2008-09-30       Impact factor: 15.992

5.  Prefrontal myo-inositol concentration and visuospatial functioning among diabetic depressed patients.

Authors:  Ebrahim Haroon; Kecia Watari; Albert Thomas; Olusola Ajilore; Jim Mintz; Virginia Elderkin-Thompson; Christine Darwin; Senthil Kumaran; Anand Kumar
Journal:  Psychiatry Res       Date:  2008-12-18       Impact factor: 3.222

6.  Interferon-alpha causes neuronal dysfunction in encephalitis.

Authors:  Andrew R Sas; Heather Bimonte-Nelson; C Thetford Smothers; John Woodward; William R Tyor
Journal:  J Neurosci       Date:  2009-03-25       Impact factor: 6.167

Review 7.  The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: novel hypothesis-driven treatments for bipolar depression?

Authors:  Joanna K Soczynska; Sidney H Kennedy; Benjamin I Goldstein; Angela Lachowski; Hanna O Woldeyohannes; Roger S McIntyre
Journal:  Neurotoxicology       Date:  2009-03-24       Impact factor: 4.294

8.  Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans.

Authors:  Lena Brydon; Neil A Harrison; Cicely Walker; Andrew Steptoe; Hugo D Critchley
Journal:  Biol Psychiatry       Date:  2008-02-01       Impact factor: 13.382

Review 9.  In vivo magnetic resonance spectroscopy: basic methodology and clinical applications.

Authors:  Marinette van der Graaf
Journal:  Eur Biophys J       Date:  2009-08-13       Impact factor: 1.733

10.  Neural origins of human sickness in interoceptive responses to inflammation.

Authors:  Neil A Harrison; Lena Brydon; Cicely Walker; Marcus A Gray; Andrew Steptoe; Raymond J Dolan; Hugo D Critchley
Journal:  Biol Psychiatry       Date:  2009-05-01       Impact factor: 13.382

View more
  53 in total

1.  Inflammation-induced motivational changes: Perspective gained by evaluating positive and negative valence systems.

Authors:  Elisabeth G Vichaya; Robert Dantzer
Journal:  Curr Opin Behav Sci       Date:  2018-02-10

Review 2.  Interoception and Inflammation in Psychiatric Disorders.

Authors:  Jonathan Savitz; Neil A Harrison
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-01-09

Review 3.  Neuroinflammation in addiction: A review of neuroimaging studies and potential immunotherapies.

Authors:  Milky Kohno; Jeanne Link; Laura E Dennis; Holly McCready; Marilyn Huckans; William F Hoffman; Jennifer M Loftis
Journal:  Pharmacol Biochem Behav       Date:  2019-01-26       Impact factor: 3.533

Review 4.  The anti-inflammatory role of SSRI and SNRI in the treatment of depression: a review of human and rodent research studies.

Authors:  Vlad Dionisie; Gabriela Adriana Filip; Mihnea Costin Manea; Mirela Manea; Sorin Riga
Journal:  Inflammopharmacology       Date:  2020-11-08       Impact factor: 4.473

Review 5.  Inflammatory cytokine-associated depression.

Authors:  Francis E Lotrich
Journal:  Brain Res       Date:  2014-07-05       Impact factor: 3.252

Review 6.  Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation.

Authors:  Andrew H Miller; Ebrahim Haroon; Jennifer C Felger
Journal:  Neuropsychopharmacology       Date:  2016-08-24       Impact factor: 7.853

7.  The relationship between interleukin-6 and functional connectivity in methamphetamine users.

Authors:  Milky Kohno; Jennifer M Loftis; Marilyn Huckans; Laura E Dennis; Holly McCready; William F Hoffman
Journal:  Neurosci Lett       Date:  2018-04-22       Impact factor: 3.046

Review 8.  The role of inflammation in depression: from evolutionary imperative to modern treatment target.

Authors:  Andrew H Miller; Charles L Raison
Journal:  Nat Rev Immunol       Date:  2016-01       Impact factor: 53.106

9.  Evidence of widespread metabolite abnormalities in Myalgic encephalomyelitis/chronic fatigue syndrome: assessment with whole-brain magnetic resonance spectroscopy.

Authors:  Christina Mueller; Joanne C Lin; Sulaiman Sheriff; Andrew A Maudsley; Jarred W Younger
Journal:  Brain Imaging Behav       Date:  2020-04       Impact factor: 3.978

Review 10.  Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.

Authors:  Ebrahim Haroon; Andrew H Miller; Gerard Sanacora
Journal:  Neuropsychopharmacology       Date:  2016-09-15       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.